Tagged: Adaptive Enrollment

Fighting the Efficiency War on Two Fronts

We welcome the news that FDA drug and biologic approvals soared to 39 in 2012. That’s the best year for approvals of new therapeutic agents since 1996, justifying all the champagne we drank on New Year’s Eve. Consistent with opinion at the recent Forbes healthcare summit, the increase in FDA approvals suggests the industry is… Read more »